Analysis of the Relationship Between MedRiPh (Medication Risk in Pharmacotherapy) Scores and the Incidence of Drug-Related Problems (DRPs) in Geriatric Patients with Comorbidities at Community Health Center X, Surabaya

Authors

  • Rissa Maharani Dewi Universitas Islam Sultan Agung, Semarang, Jawa Tengah
  • Lilik Septiana Universitas Muslim Nusantara Al-Washliyah
  • Diki Aprianto A Universitas Alma Ata
  • Ratna mildawati Stikes Ganesha Husada Kediri
  • Eka Nur Fatmawati Akbid Harapan Mulia Ponorogo

DOI:

https://doi.org/10.69855/farmasi.v1i1.387

Keywords:

Medriph Score, Drug-Related Problems, Geriatrics, Polypharmacy, Predictive Tool, Primary Healthcare, Medication Safety

Abstract

Drug-Related Problems (DRPs) remain a significant issue in geriatric pharmacotherapy, particularly among older adults with multiple chronic conditions and complex medication regimens. The MedRiPh (Medication Risk in Pharmacotherapy) scoring model has been introduced to identify patients at higher risk of medication related harm, yet its usefulness in Indonesian primary care has not been well evaluated. This cross-sectional study was conducted from October to December 2024 involving 100 geriatric patients aged ≥60 years selected using purposive sampling. MedRiPh scores were calculated using validated criteria, and DRPs were identified based on the Pharmaceutical Care Network Europe (PCNE) version 9.1 system. Statistical analysis included the Shapiro Wilk test, Spearman correlation, and linear regression. A total of 412 DRPs were recorded, with drug interactions, dosing errors, and duplicate therapies being the most common. A strong correlation was found between MedRiPh scores and DRPs (r = 0.82, p < 0.001). These results indicate that MedRiPh may be useful for improving medication safety in geriatric primary care.

References

Bankes, D., Jin, H., Finnel, S., Michaud, V., Knowlton, C., Turgeon, J., & Stein, A. (2020). Association of a novel medication risk score with adverse drug events and other pertinent outcomes among participants of the Programs of All-Inclusive Care for the Elderly. Pharmacy: Journal of Pharmacy Education and Practice, 8(2), 87. https://doi.org/10.3390/pharmacy8020087

Choukroun, C., Leguelinel-Blache, G., Roux-Marson, C., Jamet, C., Martin-Allier, A., Kinowski, J., Guillou, L., Richard, H., & Antoine, V. (2020). Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer. Journal of Geriatric Oncology, 12(1), 122–129. https://doi.org/10.1016/j.jgo.2020.07.010

Ferrández, O., Grau, S., Urbina, O., Mojal, S., Riu, M., & Salas, E. (2018). Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period. Saudi Pharmaceutical Journal, 26(5), 703–708. https://doi.org/10.1016/j.jsps.2018.02.020

Hailu, B., Berhe, D., Gudina, E., Gidey, K., & Getachew, M. (2019). Drug-related problems in admitted geriatric patients: The impact of clinical pharmacist interventions. BMC Geriatrics, 20(1), 456. https://doi.org/10.1186/s12877-020-1413-7

Hanlon, J. T., Schmader, K. E., Koronkowski, M. J., Weinberger, M., Landsman, P. B., Samsa, G. P., & Lewis, I. K. (1997). Adverse drug events in high-risk older outpatients. Journal of the American Geriatrics Society, 45(8), 945–948. https://doi.org/10.1111/j.1532-5415.1997.tb02964.x

Jung-Poppe, L., Nicolaus, H., Roggenhofer, A., Altenbuchner, A., Dormann, H., Pfistermeister, B., & Maas, R. (2022). Systematic review of risk factors assessed in predictive scoring tools for drug-related problems in inpatients. Journal of Clinical Medicine, 11(17), 5185. https://doi.org/10.3390/jcm11175185

Lavan, A., & Gallagher, P. (2016). Predicting risk of adverse drug reactions in older adults. Therapeutic Advances in Drug Safety, 7(1), 11–22. https://doi.org/10.1177/2042098615615472

Michaud, V., Smith, M., Bikmetov, R., Dow, P., Johnson, J., Stein, A., Finnel, S., Jin, H., & Turgeon, J. (2021). Association of the MedWise Risk Score with health care outcomes. The American Journal of Managed Care, 27(16 Suppl.), S280–S291. https://doi.org/10.37765/ajmc.2021.88753

Parameswaran Nair, N., Chalmers, L., Peterson, G. M., Bereznicki, B. J., Castelino, R. L., & Bereznicki, L. R. (2016). Hospitalization in older patients due to adverse drug reactions: The need for a prediction tool. Clinical Interventions in Aging, 11, 497–505. https://doi.org/10.2147/CIA.S99097

Ratigan, A., Michaud, V., Turgeon, J., Bikmetov, R., Villarreal, G., Anderson, H., Pulver, G., & Pace, W. (2021). Longitudinal association of a medication risk score with mortality among ambulatory patients acquired through electronic health record data. Journal of Patient Safety, 17(4), 249–255. https://doi.org/10.1097/PTS.0000000000000829

Ruiz-Ramos, J., Plaza-Diaz, A., Roure-i-Nuez, C., Fernández-Morató, J., González-Bueno, J., Barrera-Puigdollers, M. T., García-Peláez, M., Rudi-Sola, N., Blázquez-Andión, M., San-Martin-Paniello, C., Sampol-Mayol, C., & Juanes-Borrego, A. (2024). Drug-related problems in elderly patients attended to by emergency services. Journal of Clinical Medicine, 13(1), Article 3. https://doi.org/10.3390/jcm13010003

Ruiz-Ramos, J., Vela, E., Monterde, D., Blázquez-Andión, M., Puig-Campmany, M., Piera-Jiménez, J., Carot, G., & Juanes-Borrego, A. (2024). Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: The DICER-score. BMC Emergency Medicine, 24(1), 76. https://doi.org/10.1186/s12873-024-00946-7

Schneider, J., Algharably, E., Budnick, A., Wenzel, A., Dräger, D., & Kreutz, R. (2021). High prevalence of multimorbidity and polypharmacy in elderly patients with chronic pain receiving home care are associated with multiple medication-related problems. Frontiers in Pharmacology, 12, 686990. https://doi.org/10.3389/fphar.2021.686990

Van Dam, C., Labuschagne, H., Van Keulen, K., Kramers, C., Kleipool, E., Hoogendijk, E., Knol, W., Nanayakkara, P., Muller, M., Trappenburg, M., & Peters, M. (2022). Polypharmacy, comorbidity, and frailty: A complex interplay in older patients at the emergency department. European Geriatric Medicine, 13(5), 849–857. https://doi.org/10.1007/s41999-022-00664-y

Watanabe, J. H., McInnis, T., & Hirsch, J. D. (2018). Cost of prescription drug-related morbidity and mortality. The Annals of Pharmacotherapy, 52(9), 829–837. https://doi.org/10.1177/1060028018765159

Downloads

Published

2025-12-28

How to Cite

Rissa Maharani Dewi, Lilik Septiana, Diki Aprianto A, Ratna mildawati, & Eka Nur Fatmawati. (2025). Analysis of the Relationship Between MedRiPh (Medication Risk in Pharmacotherapy) Scores and the Incidence of Drug-Related Problems (DRPs) in Geriatric Patients with Comorbidities at Community Health Center X, Surabaya. Fundamental and Applied Research in Medicine and Allied Sciences Indonesia, 1(1), 22–33. https://doi.org/10.69855/farmasi.v1i1.387

Issue

Section

Articles